ArticleNature communications2024

Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma.

Julia Paczkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.